Next Article in Journal
Monitoring Phenolic Compounds in Rice during the Growing Season in Relation to Fungal and Mycotoxin Contamination
Next Article in Special Issue
Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease
Previous Article in Journal
Diversity and Toxigenicity of Fungi that Cause Pineapple Fruitlet Core Rot
Previous Article in Special Issue
A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear)

Monocytes in Uremia

Department of Internal Medicine II, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany
Author to whom correspondence should be addressed.
Received: 6 March 2020 / Revised: 19 May 2020 / Accepted: 19 May 2020 / Published: 21 May 2020
(This article belongs to the Special Issue Immune Dysfunction in Uremia)
Monocytes play an important role in both innate immunity and antigen presentation for specific cellular immune defense. In patients with chronic renal failure, as well as those treated with maintenance hemodialysis, these cells are largely dysregulated. There is a large body of literature on monocyte alterations in such patients. However, most of the publications report on small series, there is a vast spectrum of different methods and the heterogeneity of the data prevents any meta-analytic approach. Thus, a narrative review was performed to describe the current knowledge. Monocytes from patients with chronic renal failure differ from those of healthy individuals in the pattern of surface molecule expression, cytokine and mediator production, and function. If these findings can be summarized at all, they might be subsumed as showing chronic inflammation in resting cells together with limited activation upon immunologic challenge. The picture is complicated by the fact that monocytes fall into morphologically and functionally different populations and population shifts interact heavily with dysregulation of the individual cells. Severe complications of chronic renal failure such as impaired immune defense, inflammation, and atherosclerosis can be related to several aspects of monocyte dysfunction. Therefore, this review aims to provide an overview about the impairment and activation of monocytes by uremia and the resulting clinical consequences for renal failure patients. View Full-Text
Keywords: chronic kidney disease; cytokines; hemodialysis; inflammation; monocytes; uremic toxins chronic kidney disease; cytokines; hemodialysis; inflammation; monocytes; uremic toxins
Show Figures

Figure 1

MDPI and ACS Style

Girndt, M.; Trojanowicz, B.; Ulrich, C. Monocytes in Uremia. Toxins 2020, 12, 340.

AMA Style

Girndt M, Trojanowicz B, Ulrich C. Monocytes in Uremia. Toxins. 2020; 12(5):340.

Chicago/Turabian Style

Girndt, Matthias, Bogusz Trojanowicz, and Christof Ulrich. 2020. "Monocytes in Uremia" Toxins 12, no. 5: 340.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop